Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
Condition:   Ventricular Thrombus Interventions:   Drug: non-vitamin K antagonist oral anticoagulants (NOACs);   Drug: vitamin K antagonists (VKAs);   Drug: antiplatelet agents;   Other: non-antithrombotic therapy Sponsor:   China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
Condition:   Atrial Fibrillation Interventions:   Drug: Non-vitamin K oral anticoagulants (NOACs);   Drug: Warfarin Sponsor:   St. Paul's Hospital, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
Condition:   Ventricular Thrombus Interventions:   Drug: non-vitamin K antagonist oral anticoagulants (NOACs);   Drug: vitamin K antagonists (VKAs);   Drug: antiplatelet agents;   Other: non-antithrombotic therapy Sponsor:   China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
Condition:   Atrial Fibrillation Interventions:   Drug: Non-vitamin K oral anticoagulants (NOACs);   Drug: Warfarin Sponsor:   St. Paul's Hospital, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
Condition:   Ventricular Thrombus Interventions:   Drug: non-vitamin K antagonist oral anticoagulants (NOACs);   Drug: vitamin K antagonists (VKAs);   Drug: antiplatelet agents;   Other: non-antithrombotic therapy Sponsor:   China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

Maternal and Neonatal Benefits of Prophylactic Administration of Vitamin K Before Elective Cesarean Section
Condition:   Vitamin K Intervention:   Dietary Supplement: vitamin k Sponsors:   National Research Centre, Egypt;   Minia University, Egypt Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2021 Category: Research Source Type: clinical trials